GlassScriptPhysician profile
Saqib Rehman
NPI 1407844376
$53,911.21
in general payments reported to CMS, 2019-2025
9 companies · $7,383 in 2025
The $7,383 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,698 · 2021: $6,051 · 2022: $5,770 · 2023: $17K · 2024: $3,526 · 2025: $7,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $18K · Travel and Lodging: $4,535 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,500 · Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $18,418.31 |
| Travel and Lodging | $4,535.15 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,500.00 |
| Food and Beverage | $744.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $30,684.14 | 2019-2025 | Ankle Fracture System, Tlif, Mini Fragment System |
| Synthes Gmbh | $12,862.57 | 2019-2023 | |
| Synthes USA Products LLC | $6,001.94 | 2020-2022 | |
| Medical Device Business Services, INC. | $2,434.94 | 2019-2022 | |
| Stryker Corporation | $633.77 | 2019-2025 | Pangea |
| Liberty Surgical INC. | $517.00 | 2019 | |
| Orthoxel Designated Activity Company | $500.00 | 2019 | |
| Curvafix, INC. | $144.48 | 2024 | Curvafix Im Implant |
| Vapotherm INC | $132.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saqib Rehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.